Company Filing History:
Years Active: 2013
Title: Inventor Yu Man and His Innovation in Crystalline Form of Polydatin
Introduction
Yu Man, an innovative inventor based in Guangdong, China, has made significant contributions to the field of pharmaceutical formulations with his patented invention. His work focuses on the novel crystalline form I of 3,4',5-trihydroxy-stilbene-3-β-D-glucoside, commonly known as polydatin. This invention presents new possibilities in drug production and formulation efficiency.
Latest Patents
Yu Man holds a patent for the crystalline form I of 3,4',5-trihydroxy-stilbene-3-β-D-glucoside. This patent describes a stable crystalline morphology with a definite melting point and notable chemical stability. The advantages of this crystalline form include its suitability for solid formulations, ease of handling during production, and improved quality control in industrial environments. Furthermore, this innovation allows for a substantial reduction in raw material costs, enhancing the convenience of storage and distribution.
Career Highlights
Yu Man is currently affiliated with Shenzhen Neptunus Pharmaceutical Holdings Co., Ltd., where he leverages his expertise in pharmaceuticals to develop advanced drug formulations. His innovative approach and patent illustrate his commitment to enhancing the pharmaceutical industry.
Collaborations
Throughout his career, Yu Man has collaborated with fellow inventors such as Hui Kang and Jinhua Zhao. Together, they aim to push the boundaries of pharmaceutical research and development, contributing to safer and more efficient drug formulations.
Conclusion
Yu Man's invention of crystalline form I of 3,4',5-trihydroxy-stilbene-3-β-D-glucoside represents a notable advancement in the pharmaceutical field. His work not only showcases his talent as an inventor but also highlights the importance of innovative thinking in improving drug production processes. As the industry continues to evolve, contributions from inventors like Yu Man will be vital in meeting the growing demands for effective and efficient pharmaceutical solutions.